Abstract:Podocyte injury occurs during the initiation and development of numerous forms of glomerular disease, and antibodies targeting podocytes have become a biomarker for diagnosis and monitoring treatment response. Accumulating evidence has suggested that immunoglobulin (Ig) is expressed in non-B lineage cells, including epithelial cancer cells, myeloid cells and several types of normal cells. The main aim of the present study was to ascertain the expression of IgG in human podocytes and to determine its potential role in cellular bioactivity. The present study detected positive staining for IgG heavy chain (Ig) and its subtype 4, and the light chains and in the cytoplasm or on the membrane by immunofluorescence. In addition, positive bands were detected for Ig, 1, 3, 4, and in the lysates of a podocyte cell line by western blotting. Mass spectrometry confirmed IgG1 as an intact tetramer in the culture supernatant. Constant region transcripts of Ig, 1, 3, 4, and were identified by reverse transcription-polymerase chain reaction, and DNA sequencing of these transcripts revealed 96-99% similarity with Ig mRNAs in the National Center for Biotechnology Information database. Compared with the diverse gene rearrangements from B cell-derived Ig, podocyte-derived Ig exhibited conservative V(D)J patterns in the variable regions of Ig and chains. Furthermore, the present study investigated the mechanism underlying IgG production in these cells by examining the expression of recombination activating gene (RAG)1, RAG2 and activation-induced cytidine deaminase. The expression levels of these proteins suggested that podocyte-derived Ig and traditional Ig may be generated in a similar manner. Furthermore, small interfering RNA-mediated downregulation of IgG expression reduced podocyte viability and adhesive capabilities. These findings suggested that IgG is expressed in podocytes and that this expression may be associated with podocyte function. Due to its potential biological and clinical significance, this phenomenon warrants further investigation.

Podocyte and immune system

Understanding the podocyte immune responses in proteinuric kidney diseases: from pathogenesis to therapy

Role of the Innate Immune Response in Glomerular Disease Pathogenesis: Focus on Podocytes

Innate Immune Activity In Glomerular Podocytes

A critical role of the podocyte cytoskeleton in the pathogenesis of glomerular proteinuria and autoimmune podocytopathies

Inflammasome Activation in Podocytes: a New Mechanism of Glomerular Diseases

Expression of Immunoglobulin G in Human Podocytes, and Its Role in Cell Viability and Adhesion

Research progress of podocytes in albuminuria

Role of Podocyte in Kidney Disease

Human Podocyte Injury in the Early Course of Hypertensive Renal Injury

The Updates of Podocyte Lipid Metabolism in Proteinuric Kidney Disease

Mechanism of Protein Degradation in Glomerular Podocytes

Alteration of Podocyte Protein Expression and Localization in the Early Stage of Various Hemodynamic Conditions

Liver X Receptor Activation Induces Podocyte Injury Via Inhibiting Autophagic Activity

[New Insight in Pathogenesis of Podocyte Disfunction in Minimal Change Disease].

Calcineurin inhibitors cyclosporin A and tacrolimus protect against podocyte injury induced by puromycin aminonucleoside in rodent models.

Calcineurin Inhibitors Ameliorate PAN‐induced Podocyte Injury Through the NFAT–Angptl4 Pathway

Podocyte Autophagic Activity Plays a Protective Role in Renal Injury and Delays the Progression of Podocytopathies.

Urinary podocyte markers of disease activity, therapeutic efficacy, and long-term outcomes in acute and chronic kidney diseases

Podocyte-targeted therapies — progress and future directions

Podocytes present antigen to activate specific T cell immune responses in inflammatory renal disease.